SI1121127T1 - Oral pharmaceutical compositions containing buprenorphin - Google Patents

Oral pharmaceutical compositions containing buprenorphin

Info

Publication number
SI1121127T1
SI1121127T1 SI9930736T SI9930736T SI1121127T1 SI 1121127 T1 SI1121127 T1 SI 1121127T1 SI 9930736 T SI9930736 T SI 9930736T SI 9930736 T SI9930736 T SI 9930736T SI 1121127 T1 SI1121127 T1 SI 1121127T1
Authority
SI
Slovenia
Prior art keywords
oral pharmaceutical
pharmaceutical compositions
compositions containing
buprenorphin
containing buprenorphin
Prior art date
Application number
SI9930736T
Other languages
English (en)
Slovenian (sl)
Inventor
Mauro Valenti
Original Assignee
Famraceutici Formenti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Famraceutici Formenti S.P.A. filed Critical Famraceutici Formenti S.P.A.
Publication of SI1121127T1 publication Critical patent/SI1121127T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
SI9930736T 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin SI1121127T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1998MI002222A IT1302682B1 (it) 1998-10-16 1998-10-16 Composizioni farmaceutiche orali contenenti buprenorfina
EP99950690A EP1121127B1 (fr) 1998-10-16 1999-10-11 Compositions pharmaceutiques orales contenant buprenorphine
PCT/EP1999/007595 WO2000023079A1 (fr) 1998-10-16 1999-10-11 Compositions pharmaceutiques orales contenant buprenorphine

Publications (1)

Publication Number Publication Date
SI1121127T1 true SI1121127T1 (en) 2005-06-30

Family

ID=11380880

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930736T SI1121127T1 (en) 1998-10-16 1999-10-11 Oral pharmaceutical compositions containing buprenorphin

Country Status (15)

Country Link
US (1) US6365596B1 (fr)
EP (1) EP1121127B1 (fr)
JP (1) JP2002527480A (fr)
AT (1) ATE287264T1 (fr)
AU (1) AU752449B2 (fr)
CA (1) CA2347195C (fr)
DE (1) DE69923336T2 (fr)
DK (1) DK1121127T3 (fr)
ES (1) ES2237165T3 (fr)
HU (1) HU226166B1 (fr)
IT (1) IT1302682B1 (fr)
NZ (1) NZ511085A (fr)
PT (1) PT1121127E (fr)
SI (1) SI1121127T1 (fr)
WO (1) WO2000023079A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL204638B1 (pl) * 2001-02-16 2010-01-29 Gruenenthal Gmbh Zastosowanie buprenorfiny do wytwarzania środka leczniczego do leczenia nietrzymania moczu
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
KR20070044805A (ko) 2004-04-15 2007-04-30 키아스마, 인코포레이티드 생물학적 장벽 투과를 촉진시킬 수 있는 조성물
WO2005117838A1 (fr) * 2004-06-02 2005-12-15 Galephar M/F Compositions pharmaceutiques orales stables de buprenorphine et de derives
WO2007061828A2 (fr) * 2005-11-21 2007-05-31 Schering-Plough Ltd. Compositions pharmaceutiques
EP1897543A1 (fr) 2006-08-30 2008-03-12 Euro-Celtique S.A. Gaufre de buprénorphine pour la thérapie de substitution
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
US20090082383A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched buprenorphine
NZ591810A (en) 2008-09-17 2012-12-21 Chiasma Inc Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
DK2706986T3 (en) 2011-09-19 2015-06-01 Orexo Ab NEW ADDICTION PREVENTING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OPIOID ADDICTION
CA2923811C (fr) 2013-09-10 2021-07-27 Insys Pharma, Inc. Spray sublingual contenant de la buprenorphine
US9918981B2 (en) 2013-09-10 2018-03-20 Insys Development Company, Inc. Liquid buprenorphine formulations
US9867818B2 (en) 2013-09-10 2018-01-16 Insys Development Company, Inc. Sublingual buprenorphine spray
US9839611B2 (en) 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US9642848B2 (en) 2014-07-08 2017-05-09 Insys Development Company, Inc. Sublingual naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CA2975599A1 (fr) 2015-02-03 2016-08-11 Chiasma Inc. Methode de traitement de maladies
AU2019209416A1 (en) 2018-01-22 2020-07-30 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition for sustained release delivery of buprenorphine
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605671A (en) * 1984-09-28 1986-08-12 American Home Products Corporation Parenteral formulation
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) * 1995-04-27 1996-11-12 Green Cross Corp:The 口腔部局所投与剤
EP0914097B1 (fr) * 1996-03-12 2002-01-16 Alza Corporation Composition et forme galenique contenant un antagoniste des opioides
JP3687025B2 (ja) * 1998-06-04 2005-08-24 東和薬品株式会社 安定なマレイン酸エナラプリル錠剤

Also Published As

Publication number Publication date
HUP0103924A2 (hu) 2002-02-28
DE69923336D1 (de) 2005-02-24
PT1121127E (pt) 2005-03-31
HUP0103924A3 (en) 2003-05-28
WO2000023079A1 (fr) 2000-04-27
NZ511085A (en) 2002-10-25
HU226166B1 (en) 2008-05-28
ITMI982222A1 (it) 2000-04-16
EP1121127A1 (fr) 2001-08-08
DK1121127T3 (da) 2005-05-02
US6365596B1 (en) 2002-04-02
AU752449B2 (en) 2002-09-19
AU6337199A (en) 2000-05-08
JP2002527480A (ja) 2002-08-27
EP1121127B1 (fr) 2005-01-19
ITMI982222A0 (it) 1998-10-16
ATE287264T1 (de) 2005-02-15
ES2237165T3 (es) 2005-07-16
CA2347195C (fr) 2008-03-18
DE69923336T2 (de) 2005-05-25
CA2347195A1 (fr) 2000-04-27
IT1302682B1 (it) 2000-09-29

Similar Documents

Publication Publication Date Title
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
WO2000007979A3 (fr) Composes et compositions pour l'administration de principes actifs
HK1043064A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AP9901534A0 (en) Pharmaceutical formulations.
HUP0102676A3 (en) Solid, quick dissolving pharmaceutical compositions containing cetrizine
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
CA2366679A1 (fr) Composition pharmaceutique orale stabilisee contenant de l'iodure et de l'iodate et procede associe
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HK1045113A1 (zh) 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
EP2308479A3 (fr) Composés et compositions pour la distribution d'agents actifs
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
EP1273301A3 (fr) Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2002004012A8 (fr) Composition pharmaceutique anhydre de vancomycine a usage topique
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
HUP0303714A3 (en) Pharmaceutical compositions for dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
AU2001242819A1 (en) Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof